Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells

Natural killer (NK) cells are potent cytotoxic effector cells of the innate immune system and play an important role in tumor immunosurveillance and control. NKG2D is an activating receptor of NK cells. The NKG2D receptor-ligand system has contributed to immune cells recognizing tumor cells and the...

Full description

Saved in:
Bibliographic Details
Published inProtein expression and purification Vol. 178; p. 105783
Main Authors Zhao, Qing, Pang, Jie, Yan, Fushan, Jiang, Yi, Cui, Dongxu, Liu, Juanjuan, Jing, Lei, Li, Yuyin, Liu, Zhenxing, Tao, Li, Zhao, Xiaocui, Diao, Aipo
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Natural killer (NK) cells are potent cytotoxic effector cells of the innate immune system and play an important role in tumor immunosurveillance and control. NKG2D is an activating receptor of NK cells. The NKG2D receptor-ligand system has contributed to immune cells recognizing tumor cells and the tumor microenvironment. In order to stretch the application of NK cells on adoptive immunotherapy for B-cell malignancies, we designed and produced a novel bispecific ULBP1×CD19-scFv fusion protein, in which the extracellular domain of NKG2D ligand ULBP1 was fused to a single chain variable fragment (scFv) of anti-CD19. The vector expressing ULBP1×CD19-scFv protein was constructed and expressed in Pichia pastoris. Effects of medium composition, concentration of methanol as the inducer, induction time and broth content in shake flask on the expression of the recombinant protein were investigated. The results showed that the optimized conditions for ULBP1×CD19-scFv expression were 1% methanol induction for 96 h with 15% broth content. The secreted recombinant protein was purified using ammonium sulfate fractionation and Ni-NTA affinity chromatography and the purity is about 93%. The cytotoxicity of NK92-MI cells against CD19+ Raji cells was enhanced in the presence of purified ULBP1×CD19-scFv protein. These results indicated that ULBP1 could be used as an activating element of bispecific killer engagers (BiKEs) and Pichia pastoris yeast might be an alternative expression host for BiKEs production. •A novel bispecific ULBP1 × CD19-scFv fusion protein was constructed.•ULBP1 × CD19-scFv fusion protein was expressed in P. pastoris.•Expression condition of ULBP1 × CD19-scFv fusion protein was optimized.•ULBP1 × CD19-scFv fusion protein was purified by ammonium sulfate precipitation and His-tag affinity chromatography.•Presence of ULBP × CD19-scFv increased cytotoxic activity of NK-92 MI cells against Raji cells in vitro.
AbstractList Natural killer (NK) cells are potent cytotoxic effector cells of the innate immune system and play an important role in tumor immunosurveillance and control. NKG2D is an activating receptor of NK cells. The NKG2D receptor-ligand system has contributed to immune cells recognizing tumor cells and the tumor microenvironment. In order to stretch the application of NK cells on adoptive immunotherapy for B-cell malignancies, we designed and produced a novel bispecific ULBP1×CD19-scFv fusion protein, in which the extracellular domain of NKG2D ligand ULBP1 was fused to a single chain variable fragment (scFv) of anti-CD19. The vector expressing ULBP1×CD19-scFv protein was constructed and expressed in Pichia pastoris. Effects of medium composition, concentration of methanol as the inducer, induction time and broth content in shake flask on the expression of the recombinant protein were investigated. The results showed that the optimized conditions for ULBP1×CD19-scFv expression were 1% methanol induction for 96 h with 15% broth content. The secreted recombinant protein was purified using ammonium sulfate fractionation and Ni-NTA affinity chromatography and the purity is about 93%. The cytotoxicity of NK92-MI cells against CD19+ Raji cells was enhanced in the presence of purified ULBP1×CD19-scFv protein. These results indicated that ULBP1 could be used as an activating element of bispecific killer engagers (BiKEs) and Pichia pastoris yeast might be an alternative expression host for BiKEs production. •A novel bispecific ULBP1 × CD19-scFv fusion protein was constructed.•ULBP1 × CD19-scFv fusion protein was expressed in P. pastoris.•Expression condition of ULBP1 × CD19-scFv fusion protein was optimized.•ULBP1 × CD19-scFv fusion protein was purified by ammonium sulfate precipitation and His-tag affinity chromatography.•Presence of ULBP × CD19-scFv increased cytotoxic activity of NK-92 MI cells against Raji cells in vitro.
ArticleNumber 105783
Author Tao, Li
Zhao, Qing
Liu, Juanjuan
Li, Yuyin
Zhao, Xiaocui
Pang, Jie
Yan, Fushan
Liu, Zhenxing
Jiang, Yi
Jing, Lei
Cui, Dongxu
Diao, Aipo
Author_xml – sequence: 1
  givenname: Qing
  surname: Zhao
  fullname: Zhao, Qing
  email: zhao_qing@tust.edu.cn
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 2
  givenname: Jie
  surname: Pang
  fullname: Pang, Jie
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 3
  givenname: Fushan
  surname: Yan
  fullname: Yan, Fushan
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 4
  givenname: Yi
  surname: Jiang
  fullname: Jiang, Yi
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 5
  givenname: Dongxu
  surname: Cui
  fullname: Cui, Dongxu
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 6
  givenname: Juanjuan
  surname: Liu
  fullname: Liu, Juanjuan
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 7
  givenname: Lei
  surname: Jing
  fullname: Jing, Lei
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 8
  givenname: Yuyin
  surname: Li
  fullname: Li, Yuyin
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 9
  givenname: Zhenxing
  surname: Liu
  fullname: Liu, Zhenxing
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 10
  givenname: Li
  surname: Tao
  fullname: Tao, Li
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
– sequence: 11
  givenname: Xiaocui
  surname: Zhao
  fullname: Zhao, Xiaocui
  organization: Shunho Cell Biotech(tianjin) Co., Ltd., China
– sequence: 12
  givenname: Aipo
  surname: Diao
  fullname: Diao, Aipo
  email: diaoaipo@tust.edu.cn
  organization: School of Biotechnology, Tianjin University of Science and Technology, Key Lab of Industrial Fermentation Microbiology of the Ministry of Education, State Key Laboratory of Food Nutrition and Safety, Tianjin, 300457, China
BookMark eNp9kEFOwzAQRS0EEqVwAHZeskmxndiJxQoKLYgKWMDacp1JcdXawXYrcQDOwIG4GAmFLauZkf7_M_OO0L7zDhA6pWRECRXny1EL7YgR1s-8rPI9NKBEioywUu73fSEyLll1iI5iXBJCqSB8gD6egq83JlnvsG-wxs5vYYXnNrZgbGMNboNPYB1-mV090a_P8TWVWTSTLU46LCBZt8DpFfDD_ZRd4wAG2uQD1q7GvRQn3yesu4wfme5WbfXfuod7bGC1isfooNGrCCe_dYheJjfP49ts9ji9G1_OMkNlmTIoy7yoODWkKRkww6QhEkoq51wIyXJesYrzgjXlnOkqp4bXtaihnhPOct2Zh-hsl9ud9LaBmNTaxv4C7cBvomIFFwUVnPRSupOa4GMM0Kg22LUO74oS1SNXS9UhVz1ytUPeeS52Huh-2FoIKhoLzkBtOzBJ1d7-4_4GeOOJ8g
Cites_doi 10.1016/j.blre.2005.10.001
10.1007/s00253-014-5732-5
10.1097/PPO.0000000000000035
10.1146/annurev.immunol.23.021704.115526
10.1016/j.immuni.2012.03.007
10.1126/science.1158545
10.1182/blood-2013-02-485623
10.7150/jca.15989
10.1016/j.semcancer.2018.08.001
10.1016/j.coi.2017.11.003
10.1016/j.it.2008.04.007
10.4049/jimmunol.156.3.907
10.1016/j.ccell.2017.06.009
10.1016/j.procbio.2014.01.005
10.1182/blood-2010-08-264085
10.1126/science.285.5428.727
10.1038/nri1199
10.1016/j.copbio.2006.06.005
10.3389/fimmu.2017.00369
10.1007/s00262-016-1792-y
10.1016/j.pep.2018.05.003
10.1200/JCO.2010.32.7270
10.1038/bmt.2009.304
10.1182/blood.V118.21.252.252
10.1182/blood-2005-05-2177
10.1182/blood-2004-07-2974
10.1056/NEJMoa1215134
10.1016/j.coi.2004.11.001
10.4161/cbt.2.6.560
10.1200/JCO.2009.24.4590
10.1158/2326-6066.CIR-17-0649
10.4161/mabs.28591
10.1056/NEJMoa1103849
10.1016/j.coi.2018.03.022
10.1016/S1074-7613(01)00095-4
10.1038/sj.emboj.7600019
ContentType Journal Article
Copyright 2020 Elsevier Inc.
Copyright_xml – notice: 2020 Elsevier Inc.
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.pep.2020.105783
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
Chemistry
EISSN 1096-0279
EndPage 105783
ExternalDocumentID 10_1016_j_pep_2020_105783
S1046592820303740
GroupedDBID ---
--K
--M
.~1
0R~
123
1B1
1RT
1~.
1~5
29P
4.4
457
4G.
53G
5VS
7-5
71M
8P~
9JM
AAAJQ
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AAXUO
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABOCM
ABUDA
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADBBV
ADEZE
ADFGL
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGEKW
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CAG
CJTIS
COF
CS3
DM4
DOVZS
DU5
EBS
EFBJH
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IH2
IHE
J1W
KOM
LG5
LUGTX
LX2
M41
MO0
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSI
SSU
SSZ
T5K
WUQ
XPP
Y6R
ZA5
ZGI
ZMT
ZU3
~02
~G-
AAXKI
AAYXX
AFJKZ
AKRWK
CITATION
7X8
ID FETCH-LOGICAL-c197t-e7734851c0f72e2c29c09e719b56692358285542f7b2a831c5dd6dedb0523a773
IEDL.DBID AIKHN
ISSN 1046-5928
IngestDate Fri Oct 25 00:44:51 EDT 2024
Thu Sep 26 16:55:58 EDT 2024
Fri Feb 23 02:43:40 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Bispecific protein
Nature killer cell
Pichia pastoris
ULBP1
CD19
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c197t-e7734851c0f72e2c29c09e719b56692358285542f7b2a831c5dd6dedb0523a773
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2456416507
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2456416507
crossref_primary_10_1016_j_pep_2020_105783
elsevier_sciencedirect_doi_10_1016_j_pep_2020_105783
PublicationCentury 2000
PublicationDate February 2021
2021-02-00
20210201
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: February 2021
PublicationDecade 2020
PublicationTitle Protein expression and purification
PublicationYear 2021
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Maude, Barrett, Teachey, Grupp (bib6) 2014; 20
Pazina, Shemesh, Brusilovsky, Porgador, Campbell (bib17) 2017; 8
Ahmad, Hirz, Pichler, Schwab (bib37) 2014; 98
Wu, Teng, Xi, Wang, Wang, Mao, Zhang, Dai, Wang (bib31) 2014; 49
Reusch, Burkhardt, Fucek, Le Gall, Le Gall, Hoffmann, Knackmuss, Kiprijanov, Little, Zhukovsky (bib34) 2014; 6
Cosman, Mullberg, Sutherland, Chin, Armitage, Fanslow, Kubin, Chalupny (bib22) 2001; 14
Moretta, Moretta (bib9) 2004; 23
Lanier (bib23) 2005; 23
Ahmad, Hirz, Pichler, Schwab (bib30) 2014; 98
Jewett, Kos, Fong, Ko, Safaei, Perisic Nanut, Kaur (bib13) 2018; 53
Chan, Kang, Youssef, Glankler, Barrett, Carter, Ahmed, Prasad, Chen, Zhang, Benson, Caligiuri, Yu (bib33) 2018; 6
Kozlowska, Topchyan, Kaur, Tseng, Teruel, Hiraga, Jewett (bib12) 2017; 8
Raulet (bib24) 2003; 3
Grupp, Kalos, Barrett, Aplenc, Porter, Rheingold, Teachey, Chew, Hauck, Wright, Milone, Levine, June (bib2) 2013; 368
Teachey, Rheingold, Maude, Zugmaier, Barrett, Seif, Nichols, Suppa, Kalos, Berg, Fitzgerald, Aplenc, Gore, Grupp (bib7) 2013; 121
Hamerman, Ogasawara, Lanier (bib10) 2005; 17
López-Soto, Gonzalez, Smyth, Galluzzi (bib11) 2017; 32
Barnes, Dickson (bib36) 2006; 17
Jewett, Bonavida (bib16) 1996; 156
Makrigiannis, Anderson (bib8) 2003; 2
Topp, Kufer, Gökbuget, Goebeler, Klinger, Neumann, Horst, Raff, Viardot, Schmid, Stelljes, Schaich, Degenhard, Köhne-Volland, Brüggemann, Ottmann, Pfeifer, Burmeister, Nagorsen, Schmidt, Lutterbuese, Reinhardt, Baeuerle, Kneba, Einsele, Riethmüller, Hoelzer, Zugmaier, Bargou (bib5) 2011; 29
Miller, Soignier, Panoskaltsis-Mortari, McNearney, Yun, Fautsch, McKenna, Le, Defor, Burns (bib28) 2005; 105
S Farag, Caligiuri (bib20) 2006; 20
Moretta, Locatelli, Pende, Marcenaro, Mingari, Moretta (bib26) 2011; 117
Topp, Goekbuget, Zugmaier, Viardot, Stelljes, Neumann, Horst, Reichle, E Marks, Brueggemann, Ritgen, Klappers, Mergen, Goebeler, Einsele, Hoelzer, Bargou (bib3) 2011; 118
Zhao, Li, Guo, Wang, Liu, Zhao, Li, McKenzie, Diao (bib32) 2018; 150
Yoon, Lee, Yang, Ahn, Lee, Kim, Kang, Jeon, Seol (bib27) 2010; 45 0
Bauer, Groh, Wu, Steinle, Phillips, Lanier, Spies (bib21) 1999; 285
Rubnitz, Inaba, Ribeiro, Pounds, Rooney, Bell, Pui, Leung (bib29) 2010; 28
Porter, Levine, Kalos, Bagg, June (bib1) 2011; 365
Boudreau, Hsu (bib15) 2018; 50
von Strandmann, Hansen, Reiners, Schnell, Borchmann, Merkert, Simhadri, Draube, Reiser, Purr, Hallek, Engert (bib35) 2006; 107
Liu, Peterson, Eric (bib18) 2012; 36
Becker, Suck, Nowakowska, Ullrich, Seifried, Bader, Tonn, Seidl (bib19) 2016; 65
Gonzalez, Lopez-Soto, Suarez-Alvarez, Lopez-Vazquez, Lopez-Larrea (bib25) 2008; 29
Kaur, Nanut, Ko, Safaie, Kos, Jewett (bib14) 2018; 51
Bargou, Leo, Zugmaier, Klinger, Goebeler, Knop, Noppeney, Viardot, Hess, Schuler, Einsele, Brandl, Wolf, Kirchinger, Klappers, Schmidt, Riethmüller, Reinhardt, Baeuerle, Kufer (bib4) 2008; 321
Barnes (10.1016/j.pep.2020.105783_bib36) 2006; 17
Moretta (10.1016/j.pep.2020.105783_bib9) 2004; 23
Teachey (10.1016/j.pep.2020.105783_bib7) 2013; 121
Becker (10.1016/j.pep.2020.105783_bib19) 2016; 65
Lanier (10.1016/j.pep.2020.105783_bib23) 2005; 23
Wu (10.1016/j.pep.2020.105783_bib31) 2014; 49
Jewett (10.1016/j.pep.2020.105783_bib13) 2018; 53
Pazina (10.1016/j.pep.2020.105783_bib17) 2017; 8
von Strandmann (10.1016/j.pep.2020.105783_bib35) 2006; 107
Jewett (10.1016/j.pep.2020.105783_bib16) 1996; 156
Yoon (10.1016/j.pep.2020.105783_bib27) 2010; 45 0
Gonzalez (10.1016/j.pep.2020.105783_bib25) 2008; 29
Topp (10.1016/j.pep.2020.105783_bib3) 2011; 118
Liu (10.1016/j.pep.2020.105783_bib18) 2012; 36
Raulet (10.1016/j.pep.2020.105783_bib24) 2003; 3
Maude (10.1016/j.pep.2020.105783_bib6) 2014; 20
Ahmad (10.1016/j.pep.2020.105783_bib30) 2014; 98
S Farag (10.1016/j.pep.2020.105783_bib20) 2006; 20
Chan (10.1016/j.pep.2020.105783_bib33) 2018; 6
Grupp (10.1016/j.pep.2020.105783_bib2) 2013; 368
Cosman (10.1016/j.pep.2020.105783_bib22) 2001; 14
Hamerman (10.1016/j.pep.2020.105783_bib10) 2005; 17
Ahmad (10.1016/j.pep.2020.105783_bib37) 2014; 98
Miller (10.1016/j.pep.2020.105783_bib28) 2005; 105
Reusch (10.1016/j.pep.2020.105783_bib34) 2014; 6
Bargou (10.1016/j.pep.2020.105783_bib4) 2008; 321
López-Soto (10.1016/j.pep.2020.105783_bib11) 2017; 32
Rubnitz (10.1016/j.pep.2020.105783_bib29) 2010; 28
Porter (10.1016/j.pep.2020.105783_bib1) 2011; 365
Zhao (10.1016/j.pep.2020.105783_bib32) 2018; 150
Kozlowska (10.1016/j.pep.2020.105783_bib12) 2017; 8
Topp (10.1016/j.pep.2020.105783_bib5) 2011; 29
Kaur (10.1016/j.pep.2020.105783_bib14) 2018; 51
Bauer (10.1016/j.pep.2020.105783_bib21) 1999; 285
Moretta (10.1016/j.pep.2020.105783_bib26) 2011; 117
Boudreau (10.1016/j.pep.2020.105783_bib15) 2018; 50
Makrigiannis (10.1016/j.pep.2020.105783_bib8) 2003; 2
References_xml – volume: 8
  start-page: 369
  year: 2017
  end-page: 373
  ident: bib17
  article-title: Regulation of the functions of natural cytotoxicity receptors by interactions with diverse ligands and alterations in splice variant expression
  publication-title: Front. Immunol.
  contributor:
    fullname: Campbell
– volume: 49
  start-page: 402
  year: 2014
  end-page: 408
  ident: bib31
  article-title: Rapid cloning, expression and purification of a novel high-activity alkaline phosphatase with detoxification of lipopolysaccharide
  publication-title: Process Biochem.
  contributor:
    fullname: Wang
– volume: 50
  start-page: 102
  year: 2018
  end-page: 111
  ident: bib15
  article-title: Natural killer cell education in human health and disease
  publication-title: Curr. Opin. Immunol.
  contributor:
    fullname: Hsu
– volume: 2
  start-page: 610
  year: 2003
  end-page: 616
  ident: bib8
  article-title: Regulation of natural killer cell function
  publication-title: Canc. Biol. Ther.
  contributor:
    fullname: Anderson
– volume: 3
  start-page: 781
  year: 2003
  end-page: 790
  ident: bib24
  article-title: Roles of the NKG2D immunoreceptor and its ligands
  publication-title: Nat. Rev. Immunol.
  contributor:
    fullname: Raulet
– volume: 118
  start-page: 252
  year: 2011
  ident: bib3
  article-title: Anti-CD19 BiTE blinatumomab induces high complete remission rates in adult patients with relapsed B-precursor ALL: updated results of an on-going phase II trial
  publication-title: Blood
  contributor:
    fullname: Bargou
– volume: 14
  start-page: 123
  year: 2001
  end-page: 133
  ident: bib22
  article-title: ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
  publication-title: Immunity
  contributor:
    fullname: Chalupny
– volume: 6
  start-page: 728
  year: 2014
  end-page: 739
  ident: bib34
  article-title: A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
  publication-title: mAbs
  contributor:
    fullname: Zhukovsky
– volume: 23
  start-page: 255
  year: 2004
  end-page: 259
  ident: bib9
  article-title: Unravelling natural killer cell function: triggering and inhibitory human NK receptors
  publication-title: EMBO J.
  contributor:
    fullname: Moretta
– volume: 29
  start-page: 2493
  year: 2011
  end-page: 2498
  ident: bib5
  article-title: Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: Bargou
– volume: 53
  start-page: 178
  year: 2018
  end-page: 188
  ident: bib13
  article-title: NK cells shape pancreatic and oral tumor microenvironments role in inhibition of tumor growth and metastasis
  publication-title: Semin. Canc. Biol.
  contributor:
    fullname: Kaur
– volume: 20
  start-page: 123
  year: 2006
  end-page: 137
  ident: bib20
  article-title: Human natural killer cell development and biology
  publication-title: Blood Rev.
  contributor:
    fullname: Caligiuri
– volume: 6
  start-page: 776
  year: 2018
  end-page: 787
  ident: bib33
  article-title: A CS1-NKG2D bispecific antibody collectively activates cytolytic immune cells against multiple myeloma
  publication-title: Cancer Immunol. Res.
  contributor:
    fullname: Yu
– volume: 32
  start-page: 135
  year: 2017
  end-page: 154
  ident: bib11
  article-title: Control of metastasis by NK cells
  publication-title: Canc. Cell
  contributor:
    fullname: Galluzzi
– volume: 98
  start-page: 5301
  year: 2014
  end-page: 5317
  ident: bib30
  article-title: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
  publication-title: Appl. Microbiol. Biotechnol.
  contributor:
    fullname: Schwab
– volume: 321
  start-page: 974
  year: 2008
  end-page: 977
  ident: bib4
  article-title: Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
  publication-title: Science
  contributor:
    fullname: Kufer
– volume: 65
  start-page: 477
  year: 2016
  end-page: 484
  ident: bib19
  article-title: Selection and expansion of natural killer cells for NK cell-based immunotherapy
  publication-title: Cancer Immunol. Immunother.
  contributor:
    fullname: Seidl
– volume: 105
  start-page: 3051
  year: 2005
  end-page: 3057
  ident: bib28
  article-title: Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
  publication-title: Blood
  contributor:
    fullname: Burns
– volume: 8
  start-page: 537
  year: 2017
  end-page: 554
  ident: bib12
  article-title: Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
  publication-title: J. Canc.
  contributor:
    fullname: Jewett
– volume: 156
  start-page: 907
  year: 1996
  end-page: 915
  ident: bib16
  article-title: Target-induced inactivation and cell death by apoptosis in a subset of human NK cells
  publication-title: J. Immunol.
  contributor:
    fullname: Bonavida
– volume: 368
  start-page: 1509
  year: 2013
  end-page: 1518
  ident: bib2
  article-title: Chimeric antigen receptor–modified T cells for acute lymphoid leukemia
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: June
– volume: 20
  start-page: 119
  year: 2014
  end-page: 122
  ident: bib6
  article-title: Managing cytokine release syndrome associated with novel T cell-engaging therapies
  publication-title: Canc. J.
  contributor:
    fullname: Grupp
– volume: 29
  start-page: 397
  year: 2008
  end-page: 403
  ident: bib25
  article-title: NKG2D ligands: key targets of the immune response
  publication-title: Trends Immunol.
  contributor:
    fullname: Lopez-Larrea
– volume: 36
  start-page: 600
  year: 2012
  end-page: 611
  ident: bib18
  article-title: The adaptor protein Crk controls activation and inhibition of natural killer cells
  publication-title: Immunity
  contributor:
    fullname: Eric
– volume: 121
  start-page: 5154
  year: 2013
  end-page: 5157
  ident: bib7
  article-title: Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine directed therapy
  publication-title: Blood
  contributor:
    fullname: Grupp
– volume: 285
  start-page: 727
  year: 1999
  end-page: 729
  ident: bib21
  article-title: Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA
  publication-title: Science
  contributor:
    fullname: Spies
– volume: 23
  start-page: 225
  year: 2005
  end-page: 274
  ident: bib23
  article-title: NK cell recognition
  publication-title: Annu. Rev. Immunol.
  contributor:
    fullname: Lanier
– volume: 150
  start-page: 12
  year: 2018
  end-page: 16
  ident: bib32
  article-title: Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule, Protein Expr
  publication-title: Purif
  contributor:
    fullname: Diao
– volume: 107
  start-page: 1955
  year: 2006
  end-page: 1962
  ident: bib35
  article-title: A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
  publication-title: Blood
  contributor:
    fullname: Engert
– volume: 365
  start-page: 725
  year: 2011
  end-page: 733
  ident: bib1
  article-title: Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: June
– volume: 51
  start-page: 170
  year: 2018
  end-page: 180
  ident: bib14
  article-title: Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
  publication-title: Curr. Opin. Immunol.
  contributor:
    fullname: Jewett
– volume: 117
  start-page: 764
  year: 2011
  end-page: 771
  ident: bib26
  article-title: Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
  publication-title: Blood
  contributor:
    fullname: Moretta
– volume: 17
  start-page: 381
  year: 2006
  end-page: 386
  ident: bib36
  article-title: Mammalian cell factories for efficient and stable protein expression
  publication-title: Curr. Opin. Biotechnol.
  contributor:
    fullname: Dickson
– volume: 17
  start-page: 29
  year: 2005
  end-page: 35
  ident: bib10
  article-title: NK cells in innate immunity
  publication-title: Curr. Opin. Immunol.
  contributor:
    fullname: Lanier
– volume: 28
  start-page: 955
  year: 2010
  end-page: 959
  ident: bib29
  article-title: NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia
  publication-title: J. Clin. Oncol.
  contributor:
    fullname: Leung
– volume: 45 0
  start-page: 1038
  year: 2010
  end-page: 1046
  ident: bib27
  article-title: Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
  publication-title: Bone Marrow Transplant.
  contributor:
    fullname: Seol
– volume: 98
  start-page: 5301
  year: 2014
  end-page: 5317
  ident: bib37
  article-title: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
  publication-title: Appl. Microbiol. Biotechnol.
  contributor:
    fullname: Schwab
– volume: 20
  start-page: 123
  year: 2006
  ident: 10.1016/j.pep.2020.105783_bib20
  article-title: Human natural killer cell development and biology
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2005.10.001
  contributor:
    fullname: S Farag
– volume: 98
  start-page: 5301
  year: 2014
  ident: 10.1016/j.pep.2020.105783_bib37
  article-title: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s00253-014-5732-5
  contributor:
    fullname: Ahmad
– volume: 20
  start-page: 119
  year: 2014
  ident: 10.1016/j.pep.2020.105783_bib6
  article-title: Managing cytokine release syndrome associated with novel T cell-engaging therapies
  publication-title: Canc. J.
  doi: 10.1097/PPO.0000000000000035
  contributor:
    fullname: Maude
– volume: 23
  start-page: 225
  year: 2005
  ident: 10.1016/j.pep.2020.105783_bib23
  article-title: NK cell recognition
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.23.021704.115526
  contributor:
    fullname: Lanier
– volume: 36
  start-page: 600
  year: 2012
  ident: 10.1016/j.pep.2020.105783_bib18
  article-title: The adaptor protein Crk controls activation and inhibition of natural killer cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.03.007
  contributor:
    fullname: Liu
– volume: 321
  start-page: 974
  year: 2008
  ident: 10.1016/j.pep.2020.105783_bib4
  article-title: Tumor regression in cancer patients by very low doses of a T cell-engaging antibody
  publication-title: Science
  doi: 10.1126/science.1158545
  contributor:
    fullname: Bargou
– volume: 121
  start-page: 5154
  year: 2013
  ident: 10.1016/j.pep.2020.105783_bib7
  article-title: Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine directed therapy
  publication-title: Blood
  doi: 10.1182/blood-2013-02-485623
  contributor:
    fullname: Teachey
– volume: 8
  start-page: 537
  year: 2017
  ident: 10.1016/j.pep.2020.105783_bib12
  article-title: Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs
  publication-title: J. Canc.
  doi: 10.7150/jca.15989
  contributor:
    fullname: Kozlowska
– volume: 53
  start-page: 178
  year: 2018
  ident: 10.1016/j.pep.2020.105783_bib13
  article-title: NK cells shape pancreatic and oral tumor microenvironments role in inhibition of tumor growth and metastasis
  publication-title: Semin. Canc. Biol.
  doi: 10.1016/j.semcancer.2018.08.001
  contributor:
    fullname: Jewett
– volume: 50
  start-page: 102
  year: 2018
  ident: 10.1016/j.pep.2020.105783_bib15
  article-title: Natural killer cell education in human health and disease
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2017.11.003
  contributor:
    fullname: Boudreau
– volume: 29
  start-page: 397
  year: 2008
  ident: 10.1016/j.pep.2020.105783_bib25
  article-title: NKG2D ligands: key targets of the immune response
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2008.04.007
  contributor:
    fullname: Gonzalez
– volume: 98
  start-page: 5301
  year: 2014
  ident: 10.1016/j.pep.2020.105783_bib30
  article-title: Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s00253-014-5732-5
  contributor:
    fullname: Ahmad
– volume: 156
  start-page: 907
  year: 1996
  ident: 10.1016/j.pep.2020.105783_bib16
  article-title: Target-induced inactivation and cell death by apoptosis in a subset of human NK cells
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.156.3.907
  contributor:
    fullname: Jewett
– volume: 32
  start-page: 135
  year: 2017
  ident: 10.1016/j.pep.2020.105783_bib11
  article-title: Control of metastasis by NK cells
  publication-title: Canc. Cell
  doi: 10.1016/j.ccell.2017.06.009
  contributor:
    fullname: López-Soto
– volume: 49
  start-page: 402
  year: 2014
  ident: 10.1016/j.pep.2020.105783_bib31
  article-title: Rapid cloning, expression and purification of a novel high-activity alkaline phosphatase with detoxification of lipopolysaccharide
  publication-title: Process Biochem.
  doi: 10.1016/j.procbio.2014.01.005
  contributor:
    fullname: Wu
– volume: 117
  start-page: 764
  year: 2011
  ident: 10.1016/j.pep.2020.105783_bib26
  article-title: Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation
  publication-title: Blood
  doi: 10.1182/blood-2010-08-264085
  contributor:
    fullname: Moretta
– volume: 285
  start-page: 727
  year: 1999
  ident: 10.1016/j.pep.2020.105783_bib21
  article-title: Activation of NK cells and T cells by NKG2D, a receptor for stressinducible MICA
  publication-title: Science
  doi: 10.1126/science.285.5428.727
  contributor:
    fullname: Bauer
– volume: 3
  start-page: 781
  year: 2003
  ident: 10.1016/j.pep.2020.105783_bib24
  article-title: Roles of the NKG2D immunoreceptor and its ligands
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri1199
  contributor:
    fullname: Raulet
– volume: 17
  start-page: 381
  year: 2006
  ident: 10.1016/j.pep.2020.105783_bib36
  article-title: Mammalian cell factories for efficient and stable protein expression
  publication-title: Curr. Opin. Biotechnol.
  doi: 10.1016/j.copbio.2006.06.005
  contributor:
    fullname: Barnes
– volume: 8
  start-page: 369
  year: 2017
  ident: 10.1016/j.pep.2020.105783_bib17
  article-title: Regulation of the functions of natural cytotoxicity receptors by interactions with diverse ligands and alterations in splice variant expression
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2017.00369
  contributor:
    fullname: Pazina
– volume: 65
  start-page: 477
  year: 2016
  ident: 10.1016/j.pep.2020.105783_bib19
  article-title: Selection and expansion of natural killer cells for NK cell-based immunotherapy
  publication-title: Cancer Immunol. Immunother.
  doi: 10.1007/s00262-016-1792-y
  contributor:
    fullname: Becker
– volume: 150
  start-page: 12
  year: 2018
  ident: 10.1016/j.pep.2020.105783_bib32
  article-title: Functional recombinant human Legumain protein expression in Pichia pastoris to enable screening for Legumain small molecule, Protein Expr
  publication-title: Purif
  doi: 10.1016/j.pep.2018.05.003
  contributor:
    fullname: Zhao
– volume: 29
  start-page: 2493
  year: 2011
  ident: 10.1016/j.pep.2020.105783_bib5
  article-title: Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2010.32.7270
  contributor:
    fullname: Topp
– volume: 45 0
  start-page: 1038
  year: 2010
  ident: 10.1016/j.pep.2020.105783_bib27
  article-title: Generation of donor natural killer cells from CD34(+) progenitor cells and subsequent infusion after HLA-mismatched allogeneic hematopoietic cell transplantation: a feasibility study
  publication-title: Bone Marrow Transplant.
  doi: 10.1038/bmt.2009.304
  contributor:
    fullname: Yoon
– volume: 118
  start-page: 252
  year: 2011
  ident: 10.1016/j.pep.2020.105783_bib3
  article-title: Anti-CD19 BiTE blinatumomab induces high complete remission rates in adult patients with relapsed B-precursor ALL: updated results of an on-going phase II trial
  publication-title: Blood
  doi: 10.1182/blood.V118.21.252.252
  contributor:
    fullname: Topp
– volume: 107
  start-page: 1955
  year: 2006
  ident: 10.1016/j.pep.2020.105783_bib35
  article-title: A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
  publication-title: Blood
  doi: 10.1182/blood-2005-05-2177
  contributor:
    fullname: von Strandmann
– volume: 105
  start-page: 3051
  year: 2005
  ident: 10.1016/j.pep.2020.105783_bib28
  article-title: Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
  publication-title: Blood
  doi: 10.1182/blood-2004-07-2974
  contributor:
    fullname: Miller
– volume: 368
  start-page: 1509
  year: 2013
  ident: 10.1016/j.pep.2020.105783_bib2
  article-title: Chimeric antigen receptor–modified T cells for acute lymphoid leukemia
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1215134
  contributor:
    fullname: Grupp
– volume: 17
  start-page: 29
  year: 2005
  ident: 10.1016/j.pep.2020.105783_bib10
  article-title: NK cells in innate immunity
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2004.11.001
  contributor:
    fullname: Hamerman
– volume: 2
  start-page: 610
  year: 2003
  ident: 10.1016/j.pep.2020.105783_bib8
  article-title: Regulation of natural killer cell function
  publication-title: Canc. Biol. Ther.
  doi: 10.4161/cbt.2.6.560
  contributor:
    fullname: Makrigiannis
– volume: 28
  start-page: 955
  year: 2010
  ident: 10.1016/j.pep.2020.105783_bib29
  article-title: NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.24.4590
  contributor:
    fullname: Rubnitz
– volume: 6
  start-page: 776
  year: 2018
  ident: 10.1016/j.pep.2020.105783_bib33
  article-title: A CS1-NKG2D bispecific antibody collectively activates cytolytic immune cells against multiple myeloma
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-17-0649
  contributor:
    fullname: Chan
– volume: 6
  start-page: 728
  year: 2014
  ident: 10.1016/j.pep.2020.105783_bib34
  article-title: A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
  publication-title: mAbs
  doi: 10.4161/mabs.28591
  contributor:
    fullname: Reusch
– volume: 365
  start-page: 725
  year: 2011
  ident: 10.1016/j.pep.2020.105783_bib1
  article-title: Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1103849
  contributor:
    fullname: Porter
– volume: 51
  start-page: 170
  year: 2018
  ident: 10.1016/j.pep.2020.105783_bib14
  article-title: Natural killer cells target and differentiate cancer stem-like cells/undifferentiated tumors: strategies to optimize their growth and expansion for effective cancer immunotherapy
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2018.03.022
  contributor:
    fullname: Kaur
– volume: 14
  start-page: 123
  year: 2001
  ident: 10.1016/j.pep.2020.105783_bib22
  article-title: ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
  publication-title: Immunity
  doi: 10.1016/S1074-7613(01)00095-4
  contributor:
    fullname: Cosman
– volume: 23
  start-page: 255
  year: 2004
  ident: 10.1016/j.pep.2020.105783_bib9
  article-title: Unravelling natural killer cell function: triggering and inhibitory human NK receptors
  publication-title: EMBO J.
  doi: 10.1038/sj.emboj.7600019
  contributor:
    fullname: Moretta
SSID ssj0011605
Score 2.3306706
Snippet Natural killer (NK) cells are potent cytotoxic effector cells of the innate immune system and play an important role in tumor immunosurveillance and control....
SourceID proquest
crossref
elsevier
SourceType Aggregation Database
Publisher
StartPage 105783
SubjectTerms Bispecific protein
CD19
Nature killer cell
Pichia pastoris
ULBP1
Title Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells
URI https://dx.doi.org/10.1016/j.pep.2020.105783
https://search.proquest.com/docview/2456416507
Volume 178
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTttAEB5BOMAFUX4ElEZTCXFAMslu7Jg9pglp2qAICSJxW63ttRQEdkQCUi_ceIY-UF-sM7s2EpXaQ6_r3bU9s5qfnW9mAI6ViM6Js3kgU0MOio3agemIbiC7eSK5oDoNM9pi0h1Nw--30e0K9OtcGIZVVrLfy3QnrauRVkXN1nw2a11zdDJS5DLQOe3EIfntay5I1IC13rfxaPIWTBA-PZLnB7ygDm46mNfcctVK6Rvennf-pp7-ENRO-wy3YLMyG7Hnv-wDrNhiG3Z6BbnMDz_wBB2Q092Qb8N6v27itgOvV76iK1EfyxwNFuWzvcdkxhmWjBJCV6hhVuD08suV-PWzPxAqWKTDZ_QYcdJsSDYiTsZf5QCJVHZOXjqaIkOeisuSdyB-WzeN0yT8JS-_bjJGDgwsdmE6vLjpj4Kq80KQChUvAxtz0ZtIpO08llamUqVtZWOhErL-lMuuZXibzONEGuJ1GnFjKpslfMlsaPEeNIqysPuAJlRZFAt6HpGx0pUmFJlSWd7Os0yJJDuA05rgeu4LbOgaeXaniTuauaM9dw4grFmi350STQrgX8s-1-zTRH_-c1PY8mmhOexLJikZxYf_t_VH2JCMcnE47iNoLB-f7CcyU5ZJE1bPXkSzOoy_Aat_5F8
link.rule.ids 315,783,787,4511,24130,27938,27939,45599,45693
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTsMwDI4QHOCC-BX_GAlxQKq2ZO1KjmMwBhsVEkziFqVtKg1BO7ENiQfgGXggXgw7aZFAggPXNElb23Ls-LPN2KHkwQlyNvNEotFBMUHd0w3e9EQziwUVVMdhQltEze7Av7oP7mdYu8qFIVhlqfudTrfauhypldSsjYbD2i1FJwOJLgPKaSP00W-fQ2tAorDPtS573egrmMBdeiTN92hBFdy0MK-RoaqVwjW8PWn8djz9UNT29OksscXSbISW-7JlNmPyFbbaytFlfnqFI7BATntDvsLm21UTt1X2duMquiL1ochAQ168mEeIh5RhSSghsIUahjkM-qc3_OO9fcalN046L-Aw4niyAdqIEPUuxBkgqcwIvXTQeQo0FSYF7YD8NnYapUm4S156XdQDCgyM19igc37X7npl5wUv4TKceCakojcBT-pZKIxIhEzq0oRcxmj9SZtdS_A2kYWx0MjrJKDGVCaN6ZJZ4-J1NpsXudlgoH2ZBiHH5wEaK02hfZ5KmWb1LE0lj9NNdlwRXI1cgQ1VIc8eFHJHEXeU484m8yuWqG9SovAA-GvZQcU-hfSnP9e5KaZjRWFfNEnRKN7639b7bL57d91X_cuot80WBCFeLKZ7h81OnqdmF02WSbxXiuQnS73mXA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Production+of+a+novel+bispecific+protein+ULBP1%C3%97CD19-scFv+targeting+the+NKG2D+receptor+and+CD19+to+promote+the+activation+of+NK+cells&rft.jtitle=Protein+expression+and+purification&rft.au=Zhao%2C+Qing&rft.au=Pang%2C+Jie&rft.au=Yan%2C+Fushan&rft.au=Jiang%2C+Yi&rft.date=2021-02-01&rft.eissn=1096-0279&rft.volume=178&rft.spage=105783&rft.epage=105783&rft_id=info:doi/10.1016%2Fj.pep.2020.105783&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1046-5928&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1046-5928&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1046-5928&client=summon